Genetic alterations in metabolic genes associated with metastatic progression analyzed, revealed that genes involved in cellular fatty acid uptake (CAV1, CD36) and de novo lipogenesis (PPARA, PPARD, MLXIPL) were specifically amplified at higher frequencies in metastatic tumors (Nath and Chan, 2016). The gene discussed is PPARD; the disease is metastatic neoplasm.